HomeCompareXTN vs MRK

XTN vs MRK: Dividend Comparison 2026

XTN yields 0.81% · MRK yields 3.25%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MRK wins by $9.9K in total portfolio value
10 years
XTN
XTN
● Live price
0.81%
Share price
$90.83
Annual div
$0.73
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.8K
Annual income
$85.24
Full XTN calculator →
MRK
Merck & Co. Inc.
● Live price
3.25%
Share price
$94.80
Annual div
$3.08
5Y div CAGR
8.2%
Payout ratio
42%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.7K
Annual income
$950.29
Full MRK calculator →

Portfolio growth — XTN vs MRK

📍 MRK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodXTNMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, XTN + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
XTN pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

XTN
Annual income on $10K today (after 15% tax)
$68.74/yr
After 10yr DRIP, annual income (after tax)
$72.45/yr
MRK
Annual income on $10K today (after 15% tax)
$276.16/yr
After 10yr DRIP, annual income (after tax)
$807.75/yr
At 15% tax rate, MRK beats the other by $735.29/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of XTN + MRK for your $10,000?

XTN: 50%MRK: 50%
100% MRK50/50100% XTN
Portfolio after 10yr
$25.8K
Annual income
$517.77/yr
Blended yield
2.01%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

XTN
No analyst data
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+35.6% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

XTN buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricXTNMRK
Forward yield0.81%3.25%
Annual dividend / share$0.73$3.08
Payout ratio50%42%
1-year div growth0%5.5%
5-year div CAGR0%8.2%
Portfolio after 10y$20.8K$30.7K
Annual income after 10y$85.24$950.29
Total dividends collected$832.00$6.1K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: XTN vs MRK ($10,000, DRIP)

YearXTN PortfolioXTN Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$10,781$80.87$11,192$351.54$411.00MRK
2$11,617$81.48$12,524$392.70$907.00MRK
3$12,512$82.06$14,015$438.65$1.5KMRK
4$13,471$82.60$15,682$489.96$2.2KMRK
5$14,497$83.11$17,547$547.23$3.0KMRK
6$15,595$83.59$19,632$611.16$4.0KMRK
7$16,771$84.04$21,963$682.53$5.2KMRK
8$18,029$84.46$24,571$762.18$6.5KMRK
9$19,376$84.86$27,486$851.08$8.1KMRK
10$20,818$85.24$30,745$950.29$9.9KMRK

XTN vs MRK: Complete Analysis 2026

XTNStock

The State Street SPDR S&P Transportation ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Transportation Select Industry Index (the "Index")Seeks to provide exposure to the transportation segment of the S&P TMI, comprises the following sub-industries: Air Freight & Logistics, Airport Services, Cargo Ground Transportation, Highways & Rail Tracks, Marine Transportation, Marine Ports & Services,Passenger Airlines, Passenger Ground Transportation, and Rail TransportationSeeks to track a modified equal weighted index which provides the potential for unconcentrated industry exposure across large, mid and small cap stocksAllows investors to take strategic or tactical positions at a more targeted level than traditional sector based investing

Full XTN Calculator →

MRKHealthcare

Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.

Full MRK Calculator →
📬

Get this XTN vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

XTN vs SCHDXTN vs JEPIXTN vs OXTN vs KOXTN vs MAINXTN vs JNJXTN vs ABBVXTN vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.